Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Less than a week into 2026, many companies in the market have already posted impressive results. As of January 5th, the latest list of fast-growing companies has been released, and the performance of several top players is indeed quite remarkable.
Let's first look at the most eye-catching ones. Nebius's revenue growth reached 441.23%, and its market value has now reached $2.358 billion, ranking first among all listed companies. Protagonist Therapeutics follows closely behind, with revenue increasing by 288.98%, and its stock price has also surged by 122.68% year-to-date. Firefly Aerospace's revenue grew by 189.57%, but it's worth noting that it has fallen 66.25% from its 52-week high, indicating significant volatility.
Turning to the tech sector, CoreWeave's revenue increased by 134.07%, while Iren performed even better—revenue up 122.32%, and stock price soaring by 284.45%. Such a level of growth is quite rare.
In the energy and resources sector, there’s no slack either. Americas Gold & Silver's annual stock price increase is 425.74%, making it one of the top performers on the growth leaderboard. Talos Energy's revenue growth is only 72.51%, but it still shows steady performance within the sector.
In the pharmaceutical field, Axsome Pharmaceuticals's revenue grew by 56.13%, with a market value around $898 million. Its growth rate is moderate but stable.
A noteworthy phenomenon is that these high-growth companies generally experience significant volatility. Many companies, despite rapid revenue increases, have retraced more than 50% from their 52-week highs. Therefore, when positioning in these growth sectors, it’s important to monitor both growth data and volatility indicators—both hands are needed.
Among the listed companies, there are small-cap potential stocks and mid-cap growth players, covering the three major sectors of technology, pharmaceuticals, and energy, all of which are quite active. The investment trend for the new year is already becoming quite clear.
Honestly, Iren's 284% increase is a bit scary, at this level of market, a slight mistake can lead to being trapped
No, Firefly dropped 66% from its high and is still touting growth, this logic is really absurd
The energy sector is indeed hot this round, but it feels like everyone is betting on policies, the risk is really high
The pharmaceutical sector, Axsome's stability is pretty good, at least not as volatile as tech stocks that jump up and down
Talking about both hands, but in reality, most people only chase highs...
When Iren's stock price soared 284%, how many people got in? And now that it’s pulling back, how many are crying?
These high-growth companies all share a characteristic: revenue skyrocketing but with huge volatility, probably just a game for players
Small-cap stocks with potential are indeed many, but the gambling nature is too high...
The market trend at the start of the year is clear, but whether to follow depends on your risk tolerance
Firefly has dropped 66% from its high... Is this the fate of high-growth stocks?
A bunch of stocks have retraced over 50%. Honestly, the distance between making money and getting wiped out is a bit too close.
Technology, energy, and pharmaceuticals are all taking off, but with such big fluctuations, do you really dare to jump in?
Nebius has a 441% revenue growth rate. Why do I feel this number is a bit too "perfect"?
These kinds of stocks look good on paper, but when it comes to actually investing, you still need to see if your mindset can hold up.